Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease.
about
Leprosy & gangrene: a rare association; role of anti phospholipid antibodies.Antiphospholipid antibodies: paradigm in transition.Antiphospholipid antibodies in black south africans with hiv and acute coronary syndromes: prevalence and clinical correlates.Fluctuation in the Levels of Immunoglobulin M and Immunoglobulin G Antibodies for Cardiolipin and β2-Glycoprotein among Healthy Pregnant WomenMABGEL 1: first phase 1 trial of the anti-HIV-1 monoclonal antibodies 2F5, 4E10 and 2G12 as a vaginal microbicideClinical and laboratory characteristics of children positive for antiphospholipid antibodies.Rheumatic conditions in human immunodeficiency virus infection.Lucio's phenomenon: report of five cases.A role for interleukin-5 in promoting increased immunoglobulin M at the site of disease in leprosy.Autoantibodies in nonautoimmune individuals during infections.Lupus and leprosy: beyond the coincidence.Long-term persistence of anti-β2 glycoprotein I in treated leprosy patients.Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies.The effect of anti-tuberculosis treatment on levels of anti-phospholipid and anti-neutrophil cytoplasmatic antibodies in patients with active tuberculosis.Recurrent pulmonary thromboembolism in a patient with systemic lupus erythematosus and HIV-1 infection associated with the presence of antibodies to prothrombin: a case report.Anticardiolipin Antibodies in HIV Infection Are Independently Associated with Antibodies to the Membrane Proximal External Region of gp41 and with Cell‐Associated HIV DNA and Immune ActivationHigh frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory–thrombotic processes
P2860
Q24815078-E0DB92C2-69D6-4B62-A06D-3C7A69582010Q33382848-3A13CA01-A7BF-45F1-B72C-11E33B2B8F34Q34039698-8E2C0BAD-32B4-43D3-A4E8-0C8C87638B7EQ34380569-6AE7B52A-46A3-434B-9256-93838F67C95BQ34784621-C1A35408-996C-44EA-8010-4E6FCB508F6FQ36159957-025B419C-0291-4757-9810-B036B973F4C3Q37138780-7746DE0E-58C1-4F94-A198-75C0788B2AB9Q38215141-FEFFB485-77DD-4076-930D-C4AA6304032CQ38506036-D51CA4EF-DFD6-44B3-BC21-908E143F0D13Q40438328-9D33FB17-A238-4ECA-A381-E6F6A50514B8Q41654408-A5AA854A-BE89-4D0A-B10F-F19F7CA06BD6Q41736522-8B6F6386-3FEC-432C-81C7-461DB5E18E15Q42132261-E7368AC0-C774-45FB-A4A1-15A220C6F4B8Q44039898-DAB5EA2A-074E-432E-90BD-1DBB3780339AQ46758150-752B7BF0-ABB4-4743-BDEF-D504FDF2BDA2Q56837789-883997E4-62BD-43E9-A350-6DB232FD0B93Q59154928-400E3ACC-AD23-4022-A98F-33F24FCE7CED
P2860
Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Anticardiolipin, anti-beta(2)- ...... ients with infectious disease.
@ast
Anticardiolipin, anti-beta(2)- ...... ients with infectious disease.
@en
type
label
Anticardiolipin, anti-beta(2)- ...... ients with infectious disease.
@ast
Anticardiolipin, anti-beta(2)- ...... ients with infectious disease.
@en
prefLabel
Anticardiolipin, anti-beta(2)- ...... ients with infectious disease.
@ast
Anticardiolipin, anti-beta(2)- ...... ients with infectious disease.
@en
P2093
P2860
P356
P1476
Anticardiolipin, anti-beta(2)- ...... ients with infectious disease.
@en
P2093
P2860
P304
P356
10.1136/ARD.62.11.1106
P407
P577
2003-11-01T00:00:00Z